Artella, Future Cardia expand into sleep diagnostics through PranaQ partnership
By HME News Staff
Updated 10:20 AM CST, Thu November 20, 2025
HOUSTON & TAMPA, Fla. – Artella Solutions and Future Cardia have announced an expanded strategic collaboration with PranaQ, a digital health company pioneering smart home sleep testing (HST) solutions. This partnership marks Artellas’s expansion into sleep diagnostics, driven by the clinically proven connection between obstructive sleep apnea (OSA) and atrial fibrillation (AFib). “We built Artella to simplify diagnostic workflows for clinicians,” said Sepand Moshiri, Artella Solutions co-founder and CEO. “Integrating sleep testing into the platform gives practices a streamlined way to manage two highly correlated conditions with one partner,” Through the partnership, PranaQ’s FDA-HST system will be offered through Artella’s Active State Monitoring platform, enabling cardiology practices and hospital systems to easily order, track and manage sleep studies within Artella’s existing diagnostic ecosystem, branded as CARDIOSLEEP. Key platform benefits include:
-
Turn-key sleep diagnostic workflow for clinical practices
-
Automated study logistics and reporting workflow
-
A unified experience for practices already leveraging Artella for cardiac monitoring
“PranaQ is focused on improving access to sleep diagnostics,” said Jerry Chen, CEO of PranaQ. “Partnering with Artella brings our home sleep testing ecosystem into cardiology settings that see OSA every day but don’t always have an efficient pathway to diagnose it.”
Comments